Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| IRIDEX CORPIRIX · Entity 7882 | Director | December 16, 2025 | December 18, 2025 |
| NATUS MEDICAL INCBABY · Entity 125256 | Director | May 16, 2018 | May 18, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
IRIDEX CORP
Report date December 16, 2025 · Filed December 18, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 251,550 |
Reported balance
After 2025-12-16 transaction · row 1
1 source rowRow 1 · 2025-12-16 · Purchase · Acquired 2,000 · Balance 251,550 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 69,300 |
Reported balance
Holding disclosure · report date 2025-12-16 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 69,300 |
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 81,150 |
Reported balance
Holding disclosure · report date 2025-12-16 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 81,150 F1: The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares are held by William M. Moore Trust, William M. Moore, Trustee Under Agreement Dated 08/16/2016 & Patricia A. Moore Trust, Patricia A. Moore, Trustee Under Agreement Dated 08/17/2016 Tenants in Common.
NATUS MEDICAL INC
Report date May 16, 2018 · Filed May 18, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | IndirectBy Family Trust | 94,402 |
Reported balance
After 2018-05-16 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2018-05-16 · Exercise / conversion · Acquired 5,000 · Balance 94,402 |
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | IndirectBy Family Trust | 89,402 |
Reported balance
After 2018-05-16 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2018-05-16 · Sale · Disposed 5,000 · Balance 89,402 F1: This transaction was executed in multiple trades at prices ranging from $35.90 to $35.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | IndirectBy Family Trust | 92,402 |
Reported balance
After 2018-05-16 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-05-16 · Exercise / conversion · Acquired 3,000 · Balance 92,402 |
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | IndirectBy Family Trust | 89,402 |
Reported balance
After 2018-05-16 transaction · row 4
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 4 · 2018-05-16 · Sale · Disposed 3,000 · Balance 89,402 F1: This transaction was executed in multiple trades at prices ranging from $35.90 to $35.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $10.69 · Expires 2018-06-08 | IndirectBy Family Trust | 0 |
Reported balance
After 2018-05-16 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2018-05-16 · Exercise / conversion · Disposed 5,000 · Balance 0 |
| Nonqualified Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $24.50 · Expires 2020-06-05 | IndirectBy Family Trust | 0 |
Reported balance
After 2018-05-16 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2018-05-16 · Exercise / conversion · Disposed 3,000 · Balance 0 |
| Common Stock, $0.001 par value per shareSEC Table I · non-derivative | Direct | 30,410 |
Reported balance
Holding disclosure · report date 2018-05-16 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 30,410 |
| Common Stock, $0.001 par vale per shareSEC Table I · non-derivative | IndirectBy Spouse | 4,150 |
Reported balance
Holding disclosure · report date 2018-05-16 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 4,150 |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $35.90 to $35.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 10, 2017 Filed Mar 14, 2017 22:10 UTC | IRIDEX CORP IRIX · Entity 7882 | Exercise / conversionCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001261380-17-000002 · edgar.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 350,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 16:48 UTC | NATUS MEDICAL INC BABY · Entity 125256 | SaleCommon Stock, $0.001 par value per share | 5,000 | $37.26 | $186,300.00 |
DisclosureSEC source: 0000878526-17-000023 · wf-form4_148883690391615.xml · nonDerivative · entry 1 MOORE WILLIAM M · CIK 0001217126 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 92,402 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.